Assessment of survival in patients with idiopathic pulmonary fibrosis (IPF) using quantitative HRCT indexes

S. Torrisi (Catania, Italy), S. Palmucci (Catania, Italy), R. Rosso (Catania, Italy), M. Schisano (Catania, Italy), M. Pavone (Catania, Italy), A. Vancheri (Catania, Italy), G. Sambataro (Catania, Italy), C. Crimi (Catania, Italy), A. Stefano (PalermoPaPCatania, Italy), G. Russo (Palermoatania, Italy), C. Vancheri (Catania, Italy)

Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Session: What is new in idiopathic interstitial pneumonias?
Session type: Poster Discussion
Number: 5243
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Torrisi (Catania, Italy), S. Palmucci (Catania, Italy), R. Rosso (Catania, Italy), M. Schisano (Catania, Italy), M. Pavone (Catania, Italy), A. Vancheri (Catania, Italy), G. Sambataro (Catania, Italy), C. Crimi (Catania, Italy), A. Stefano (PalermoPaPCatania, Italy), G. Russo (Palermoatania, Italy), C. Vancheri (Catania, Italy). Assessment of survival in patients with idiopathic pulmonary fibrosis (IPF) using quantitative HRCT indexes. 5243

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Correlations of quantitative HRCT score in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Quantitative HRCT score in idiopathic pulmonary fibrosis (IPF): correlation with pulmonary function tests (PFT)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Analysis of baseline characteristics by emphysema extent in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017


HRCT score to control and evaluate the prognosis in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011


Prognostic evaluation in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality
Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses
Year: 2017



The effect of emphysema in patients with idiopathic pulmonary fibrosis; evaluation using quantitative CT analysis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


High-resolution CT (HRCT) reflects disease progression in patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017

Correlation between pulmonary function tests and HRCT indexes in Idiopathic Pulmonary Fibrosis (IPF) patients
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018

Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases
Year: 2013


Correlation of dyspnea scores with pulmonary function, high-resolution computed tomography (HRCT) and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 305s
Year: 2006

Functional and prognostic significance of relationship between VC and TLC in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2005; 26: Suppl. 49, 334s
Year: 2005

Visual and fully-automated CT analysis in acute exacerbations of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018



Ifigenia study on N -acetylcystine in idiopathic pulmonary fibrosis (IPF): comparison of HRCT and lung biopsy
Source: Eur Respir J 2001; 18: Suppl. 33, 527s
Year: 2001

Genetic predictors of idiopathic pulmonary fibrosis (IPF) prognosis
Source: Eur Respir J 2006; 28: Suppl. 50, 830s
Year: 2006

Differences in FVC decline by extent of emphysema in patients with combined pulmonary fibrosis and emphysema (CPFE) syndrome
Source: International Congress 2015 – New frontiers in the management of interstitial and orphan lung diseases
Year: 2015

Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
Source: Eur Respir J 2011; 37: 176-183
Year: 2011



Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011

Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020